Le rein de l'enfant face à la chimiothérapie [The kidney in children under chemotherapy].

Détails

ID Serval
serval:BIB_1D067B31B465
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
Le rein de l'enfant face à la chimiothérapie [The kidney in children under chemotherapy].
Périodique
Revue Médicale de la Suisse Romande
Auteur(s)
Cachat F., Guignard J.P.
ISSN
0035-3655 (Print)
ISSN-L
0035-3655
Statut éditorial
Publié
Date de publication
1996
Volume
116
Numéro
12
Pages
985-993
Langue
français
Notes
Publication types: English Abstract ; Journal Article ; ReviewPublication Status: ppublish
Résumé
Nowadays more and more children survive after an intensive anti-tumoral therapy. The price to pay consists of numerous and relatively frequent long-term sequelae (secondary tumors, neuropsychological deficits, endocrine or cardiac damage). After chemotherapy, we sometimes observe renal side-effects, either tubular (metabolic acidosis, hypokalemia, hypomagnesemia, proteinuria, Fanconi syndrome, rickets) or glomerular (acute or chronic decreased GFR). These renal toxic side-effects are encountered especially after cisplatinum and ifosfamide, less frequently after carboplatin and cyclophosphamide. The pediatrician has to be aware of these toxic nephrologic side-effects, to look out for them and monitor carefully the renal function of all paediatric patients receiving these potentially nephrotoxic chemotherapies.
Mots-clé
Antineoplastic Agents/adverse effects, Antineoplastic Agents/toxicity, Antineoplastic Agents, Alkylating/adverse effects, Carboplatin/adverse effects, Child, Cisplatin/adverse effects, Glomerular Filtration Rate/drug effects, Humans, Ifosfamide/adverse effects, Kidney/drug effects, Kidney Diseases/chemically induced, Kidney Diseases/diagnosis, Kidney Function Tests, Methotrexate/adverse effects, Mitomycin/adverse effects, Semustine/adverse effects
Pubmed
Création de la notice
24/04/2013 11:27
Dernière modification de la notice
03/03/2018 14:33
Données d'usage